These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11020835)

  • 21. What can be learned from open direct comparative trials in multiple sclerosis?
    Khan O
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S25-8. PubMed ID: 19200861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of deception to achieve double-blinding in a clinical trial of Melaleuca alternifolia (tea tree) oil for the treatment of recurrent herpes labialis.
    Carson CF; Smith DW; Lampacher GJ; Riley TV
    Contemp Clin Trials; 2008 Jan; 29(1):9-12. PubMed ID: 17544340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomization for clinical research: an easy-to-use spreadsheet method.
    Padhye NS; Cron SG; Gusick GM; Hamlin SK; Hanneman SK
    Res Nurs Health; 2009 Oct; 32(5):561-6. PubMed ID: 19606450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A generic minimization random allocation and blinding system on web.
    Cai H; Xia J; Xu D; Gao D; Yan Y
    J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S; Marziniak M; Frese A; Gralow I
    Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomization procedures in orthopaedic trials.
    Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
    Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?
    Evans KR; Sills T; Wunderlich GR; McDonald HP
    J Psychiatr Res; 2004; 38(4):437-44. PubMed ID: 15203296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blinded assessment of treatment effects utilizing information about the randomization block length.
    Miller F; Friede T; Kieser M
    Stat Med; 2009 May; 28(12):1690-706. PubMed ID: 19340815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials in urology: how many patients are required to achieve statistically significant results?
    Parazzini F; Colli E; Chatenoud L; Malvezzi M; Olivieri L; Montorsi F; La Vecchia C
    BJU Int; 2005 Apr; 95(5):717-22. PubMed ID: 15784083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edta chelation therapy: an ethical problem.
    Christensen K; Theilade D
    Med Hypotheses; 1999 Jul; 53(1):69-70. PubMed ID: 10499828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How well does blinding work in randomized controlled trials?: a counterpoint.
    Boehmer J; Yong P
    Clin Pharmacol Ther; 2009 May; 85(5):463-5. PubMed ID: 19381149
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental studies].
    Gili M; Lacalle JR; Velasco A
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):52-7. PubMed ID: 2095906
    [No Abstract]   [Full Text] [Related]  

  • 35. [Introduction of dynamic balancing randomization method and its application].
    Liu ZL; Liu BQ; Li LH; Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):246-51. PubMed ID: 21419076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Roaming through methodology. XVII. The placebo effect].
    de Craen AJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):322-4. PubMed ID: 10707743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critique of the double-blind clinical trial. Part 1.
    Kiene H
    Altern Ther Health Med; 1996 Jan; 2(1):74-80. PubMed ID: 8795875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical aspects of randomization and blinding in randomized clinical trials.
    Bridgman S; Engebretsen L; Dainty K; Kirkley A; Maffulli N;
    Arthroscopy; 2003 Nov; 19(9):1000-6. PubMed ID: 14608321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing allocation concealment and blinding in randomised controlled trials: why bother?
    Schulz KF
    Evid Based Nurs; 2001 Jan; 4(1):4-6. PubMed ID: 11707879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.